United Kingdom18 days leftOpen

Next Generation Sequencing Testing (NGS)

Tender Overview

LOCATION

Gloucestershire, Wiltshire and Bristol/Bath area, United Kingdom

VALUE

£660,000

DEADLINE

February 20, 2026 at 12:00

CATEGORY

Other

CPV CODE

72225000

REFERENCE

006523-2026

Project Timeline

Contact Information

View Original

Original Tender Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
⚠️

MANDATORY EXCLUSION GROUNDS

  • None explicitly mentioned in the provided tender information.

ELIGIBILITY REQUIREMENTS

  • Possess EU Good Manufacturing Practice (GMP) licensure.
🔧

TECHNICAL CAPABILITY REQUIREMENTS

  • Provide Next Generation Sequencing (NGS) QC testing services.
  • Deliver services for the Cellular and Molecular Therapies (CMT) directorate, specifically the Clinical Biotechnology Centre (CBC).
  • Be capable of performing NGS QC testing for Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs).
  • Ensure NGS QC testing services meet specific regulatory requirements.
  • Adhere to specific regulatory standards.
  • Ensure regulatory compliance for ATMPs and MCBs.
💰

FINANCIAL REQUIREMENTS

  • None explicitly mentioned in the provided tender information.
📋

SUBMISSION REQUIREMENTS

  • Submit the bid by the deadline: 2026-02-20 at 12:00:00 UTC.

Requirements Preview

Sign up to view complete requirements and analysis

AI-powered requirement analysis
Complete compliance breakdown
Strategic bidding insights
Instant eligibility check

No credit card required • Setup in 2 minutes

DOC
OCDS Record
OCDS Data006523-2026_ocds_record.json
Summary:
NHS Blood and Transplant seeks a provider for Next Generation Sequencing (NGS) QC testing services for its Cellular and Molecular Therapies directorate, specifically the Clinical Biotechnology Centre, to ensure regulatory compliance for Advanced Therapeutic Investigational Medicinal Products (ATMPs) and master cell banks (MCBs).
DOC
OCDS Release Package
OCDS Data006523-2026_ocds_release.json
Summary:
This OCDS Release Package provides structured data detailing NHS Blood and Transplant's open tender for Next Generation Sequencing (NGS) QC testing services for its Cellular and Molecular Therapies directorate.
PDF
Official PDF Version
Administrative Documents006523-2026_official.pdf
Summary:
NHS Blood and Transplant seeks a provider for Next Generation Sequencing (NGS) QC testing services for its Clinical Biotechnology Centre, requiring compliance with specific regulatory requirements, including EU Good Manufacturing Practice (GMP) licensing.
HTM
Tender Notice
General Information006523-2026.html
Summary:
NHS Blood and Transplant seeks a provider for Next Generation Sequencing (NGS) QC testing services for Advanced Therapeutic Investigational Medicinal Products (ATMPs) and master cell banks, requiring EU Good Manufacturing Practice (GMP) licensure and adherence to specific regulatory standards.

Documents Preview

Sign up to view document summaries and analysis

AI document summaries
Key requirement extraction
Risk & compliance alerts
Strategic document insights

No credit card required • Setup in 2 minutes

72
Good

Tender Quality Score

This tender for Next Generation Sequencing (NGS) QC testing services is clear in its technical requirements and well-structured in basic information, but significantly hampered by the absence of explicit evaluation criteria and mandatory exclusion grounds, alongside a lack of e-submission.

Score Breakdown

Legal Compliance75/100

The tender clearly defines the procedure type and CPV code, and there are no reported disputes. However, the explicit absence of mandatory exclusion grounds in the provided information and the lack of specified evaluation criteria are significant legal compliance concerns.

No explicit mandatory exclusion grounds mentioned in the provided tender information.
Missing evaluation criteria.
Clarity80/100

The description of the required NGS QC testing services and technical capabilities is clear and unambiguous. However, the critical absence of specified evaluation criteria significantly reduces the overall clarity for potential bidders.

No evaluation criteria specified.
Completeness70/100

Basic information, estimated value, duration, and documents are provided. However, the tender is incomplete due to the explicit lack of evaluation criteria and the absence of detailed financial requirements for bidders beyond the estimated value.

Missing evaluation criteria.
No explicit financial requirements mentioned for bidders.
Fairness65/100

While the tender value is disclosed and documents are accessible, the absence of evaluation criteria severely compromises transparency and fairness. The lack of e-submission also creates potential barriers to equal access for all bidders.

No evaluation criteria specified, impacting transparency and objectivity.
No e-submission supported, potentially limiting equal access.
Practicality65/100

The contract start date and duration are clearly specified. However, the absence of electronic submission support is a significant practical drawback in modern procurement, potentially increasing administrative burden for bidders.

No e-submission supported.
Data Consistency90/100

The tender information is largely consistent, with all key fields populated and logical dates. There are no reported suspensions or disputes, indicating good internal data integrity.

Sustainability50/100

The tender does not explicitly incorporate green procurement, social aspects, or innovation focus. As a specialized service procurement, these elements are not always mandatory but their absence means no positive contribution to sustainability scores.

No explicit green procurement criteria.
No explicit social criteria.

Strengths

Clear description of required services and technical capabilities.
Estimated value, contract duration, and start date are well-defined.
All relevant tender documents are available.
Open procedure with competitive characteristics.
High data consistency across provided information.

Concerns

Critical absence of explicit evaluation criteria.
Lack of explicit mandatory exclusion grounds in the provided information.
No support for electronic submission (e-submission).
Absence of detailed financial requirements for bidders.
No integration of sustainability, social, or innovation aspects.

Recommendations

1. Mandate the inclusion of clear, objective, and transparent evaluation criteria.
2. Ensure all mandatory exclusion grounds are explicitly stated in the tender documents.
3. Implement an e-submission platform to enhance fairness and streamline the bidding process.

AI Scoring Preview

Sign up to view complete requirements and analysis

Complete quality score analysis
Detailed sub-score breakdown
Strengths & concerns insights
Strategic recommendations

No credit card required • Setup in 2 minutes

Generate DocumentsReview Documents
B
Tender Quality Score
72/ 100 · Good

Tender Assistant

Ask me anything about this tender

Tender Assistant

Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.

What are the main requirements?
When is the deadline?
Who is eligible to bid?

No credit card required

Setup in 2 minutes

Save with Notes